ACNB(ACNB)
ACNB
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $169M | $174M |
| Low | $169M | $173M |
| High | $170M | $175M |
| EBITDA Avg | $63M | $64M |
| Low | $62M | $64M |
| High | $63M | $65M |
| EBIT Avg | $57M | $59M |
| Low | $57M | $58M |
| High | $57M | $59M |
| Net Income Avg | $59M | $59M |
| Low | $58M | $58M |
| High | $59M | $60M |
| EPS Avg | $5.66 | $5.69 |
| Low | $5.63 | $5.63 |
| High | $5.69 | $5.78 |
| Analysts (Rev / EPS) | 3 / 3 | 3 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $43M | $43M | $42M | $44M | $44M | $44M |
| Low | $43M | $43M | $42M | $44M | $44M | $43M |
| High | $43M | $43M | $43M | $44M | $44M | $44M |
| EBITDA Avg | $16M | $16M | $16M | $16M | $16M | $16M |
| Low | $16M | $16M | $16M | $16M | $16M | $16M |
| High | $16M | $16M | $16M | $16M | $16M | $16M |
| EBIT Avg | $15M | $14M | $14M | $15M | $15M | $15M |
| Low | $14M | $14M | $14M | $15M | $15M | $15M |
| High | $15M | $14M | $14M | $15M | $15M | $15M |
| Net Income Avg | $15M | $14M | $14M | $15M | $15M | $15M |
| Low | $15M | $14M | $14M | $15M | $15M | $14M |
| High | $15M | $15M | $14M | $15M | $15M | $15M |
| EPS Avg | $1.47 | $1.41 | $1.34 | $1.46 | $1.47 | $1.43 |
| Low | $1.45 | $1.39 | $1.34 | $1.45 | $1.46 | $1.42 |
| High | $1.48 | $1.44 | $1.35 | $1.46 | $1.47 | $1.43 |
| Analysts (Rev / EPS) | 3 / 3 | 3 / 3 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |